Topic

Pennsylvania

A collection of 524 issues

How to Get Somatuline Depot (Lanreotide) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: UnitedHealthcare requires prior authorization for Somatuline Depot (lanreotide) in Pennsylvania, typically under medical benefit (HCPCS J1930) with step therapy requiring prior octreotide trial. Submit PA via UHC Provider Portal with diagnosis confirmation, prior therapy records, and specialist documentation. If denied, file internal appeals within 65 days (Medicare Advantage)

How to Get Brineura (Cerliponase Alfa) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Brineura Covered by Blue Cross Blue Shield in Pennsylvania Brineura (cerliponase alfa) requires prior authorization from Blue Cross Blue Shield plans in Pennsylvania, including Highmark and Independence Blue Cross. Coverage is approved for pediatric patients with confirmed CLN2 disease (TPP1 deficiency) when administered at specialized centers by

How to Get Qinlock (Ripretinib) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Qinlock (ripretinib) requires prior authorization from Aetna CVS Health in Pennsylvania. You'll need documented failure of three prior kinase inhibitors (imatinib, sunitinib, regorafenib), submit through the CVS Caremark portal or CoverMyMeds, and allow 15 business days for standard review. If denied, Pennsylvania's new external

How to Get Oxlumo (Lumasiran) Covered by Cigna in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Oxlumo Covered by Cigna in Pennsylvania Cigna requires prior authorization for Oxlumo (lumasiran) with genetic confirmation of PH1, elevated urinary oxalate levels, and prescription by a nephrologist or urologist. Submit PA through CoverMyMeds or EviCore portal with AGXT mutation results and baseline labs. If denied, use Cigna&

How to Get Blenrep (belantamab mafodotin) Covered by Aetna (CVS Health) in Pennsylvania: Appeals Guide with Forms and Timelines

Answer Box: Getting Blenrep Covered in Pennsylvania Blenrep (belantamab mafodotin) received FDA approval on October 23, 2025, for adults with relapsed or refractory multiple myeloma. Aetna (CVS Health) requires prior authorization through CVS Caremark for this specialty drug. If denied, Pennsylvania's external review program overturns approximately 50% of

How to Get Abecma (idecabtagene vicleucel) Covered by Humana in Pennsylvania: Complete Guide to Prior Authorization and Appeals

Quick Answer: Abecma (idecabtagene vicleucel) requires prior authorization from Humana Medicare Advantage plans for adults with relapsed/refractory multiple myeloma after ≥4 prior therapy lines. Submit through Humana's National Transplant Network at 866-421-5663 with complete treatment history documentation. If denied, Pennsylvania's new Independent External Review program

Get Amvuttra (Vutrisiran) Covered by Humana in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Amvuttra (Vutrisiran) Covered by Humana in Pennsylvania Quick Path to Approval: Amvuttra (vutrisiran) requires prior authorization from Humana for TTR amyloidosis treatment. Your fastest route: gather genetic testing results confirming hereditary ATTR or cardiac imaging showing ATTR-CM, schedule a specialist visit to document disease stage, and submit

Coding That Helps Get Hemgenix (etranacogene dezaparvovec) Approved by Humana in Pennsylvania: ICD-10, HCPCS, and Billing Guide

Answer Box: Getting Hemgenix Covered by Humana in Pennsylvania Hemgenix (etranacogene dezaparvovec) requires prior authorization from Humana and bills under your medical benefit using HCPCS code J1411. Key steps: (1) Use ICD-10 code D67 for hemophilia B with documented factor IX levels ≤5 IU/dL, (2) Submit PA through Humana&

Getting Palynziq Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide 2025

Quick Answer: Getting Palynziq Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Palynziq (pegvaliase-pqpz) with mandatory 4-week sapropterin trial first. If denied, Pennsylvania's new Independent External Review program overturns 50% of appeals. Start today: Have your PKU specialist gather blood phenylalanine levels >600 µmol/L,

How to Get Myozyme (Alglucosidase Alfa) Covered by Blue Cross Blue Shield in Pennsylvania: Forms, Appeals, and Success Strategies

Answer Box: Your Path to Coverage Getting Myozyme (alglucosidase alfa) covered by Blue Cross Blue Shield in Pennsylvania requires prior authorization with confirmed Pompe disease diagnosis via genetic testing and enzyme activity levels. Start today by: (1) calling your specific Blue plan (Highmark or Independence Blue Cross) to request the